We are actively responding to the global COVID-19 pandemic. For more, please visit our COVID-19 response page, or call 1-877-436-3683. See the latest update on Actemra® (tocilizumab) supply here.

Science Briefs

Science Briefs

Our scientists are committed to exploring the unknown frontiers of science. Learn more about the latest discoveries from our labs.